Skip to main content
Midas Edge

Inspire Medical Systems, Inc.

For the period ended Sep 30, 2025. Filed Nov 3, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 3, 2025

INSP$64.33+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Statements of Stockholders' Equity

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Nine Months Ended September 30, 2025
Common Stock
SharesAmountAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncomeAccumulatedDeficitTotalStockholders'Equity
Balance at December 31, 202429,740,176$30$981,043$536$(291,914)$689,695
Stock options exercised73,491—6,441——6,441
Vesting of restricted stock units and performance stock units, net199,778—(19,192)——(19,192)
Issuance of common stock390—69——69
Stock-based compensation expense——31,056——31,056
Accelerated share repurchase of common stock(103,886)—————
Share repurchase of common stock(442,649)(1)(75,008)——(75,009)
Other comprehensive loss———(309)—(309)
Net income————2,9922,992
Balance at March 31, 202529,467,30029924,409227(288,922)635,743
Stock options exercised43,691—2,174——2,174
Vesting of restricted stock units and performance stock units, net28,487—(1,732)——(1,732)
Issuance of common stock490—73——73
Issuance of common stock for employee stock purchase plan29,509—3,255——3,255
Stock-based compensation expense——41,724——41,724
Other comprehensive income———169—169
Net loss————(3,592)(3,592)
Balance at June 30, 202529,569,47729969,903396(292,514)677,814
Stock options exercised11,685—144——144
Vesting of restricted stock units and performance stock units, net23,995—(1,224)——(1,224)
Issuance of common stock633—84——84
Stock-based compensation expense——29,467——29,467
Share repurchase of common stock(552,423)—(50,000)——(50,000)
Other comprehensive income———243—243
Net income————9,9329,932
Balance at September 30, 202529,053,367$29$948,374$639$(282,582)$666,460

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Nine Months Ended September 30, 2024
Common Stock
Shares · Amount · AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · TotalStockholders'Equity
Balance at December 31, 202329,560,464$30$917,107$800$(345,423)$572,514
Stock options exercised88,276—3,616——3,616
Vesting of restricted stock units41,185—————
Shares held for tax withholdings(14,373)—(2,848)——(2,848)
Issuance of common stock543—101——101
Stock-based compensation expense——26,322——26,322
Other comprehensive loss———(676)—(676)
Net loss————(10,005)(10,005)
Balance at March 31, 202429,676,09530944,298124(355,428)589,024
Stock options exercised88,328—5,517——5,517
Vesting of restricted stock units21,340—————
Shares held for tax withholdings(10,985)—(1,862)——(1,862)
Issuance of common stock365—85——85
Issuance of common stock for employee stock purchase plan30,158—3,431——3,431
Stock-based compensation expense——32,322——32,322
Other comprehensive loss———(239)—(239)
Net income————9,7939,793
Balance at June 30, 202429,805,30130983,791(115)(345,635)638,071
Stock options exercised152,106—14,226——14,226
Vesting of restricted stock units10,273——
Issuance of common stock469—65——65
Shares held for tax withholdings(4,889)—(4,335)——(4,335)
Stock-based compensation expense——28,223——28,223
Other comprehensive income———1,815—1,815
Net income————18,49718,497
Balance at September 30, 202429,963,260$30$1,021,970$1,700$(327,138)$696,562
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.